Celgene Corporation Securities Litigation Settlement
Last verified September 18, 2026Source: jndHow ClaimWatch verifies cases
This settlement is closed to new claims — the deadline was April 13, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Celgene Corporation and certain of its officers violated federal securities laws by making false and misleading statements regarding pharmaceutical drugs and drug candidates, including GED-0301, Otezla, and Ozanimod during the class period. The defendants' misconduct allegedly damaged investors who purchased Celgene common stock.
Do you qualify?
All persons and entities who purchased Celgene common stock between April 27, 2017 and April 27, 2018 (inclusive) and were damaged thereby. Excluded are the defendants, company directors and officers, their families, Celgene subsidiaries and affiliates, and those who previously requested exclusion.
Who is in the class
All persons and entities who purchased the common stock of Celgene between April 27, 2017 and April 27, 2018, inclusive, and were damaged thereby
Quoted from the settlement notice.
How to file
Submit a Claim Form with required supporting documentation postmarked or submitted online by April 13, 2026. The Claim Form is available on the File a Claim page at celgenesecuritieslitigation.com. Contact the Claims Administrator at 1-855-648-0893, info@CelgeneSecuritiesLitigation.com, or mail to the address listed for assistance.
Common questions
- How much does the Celgene Corporation Securities Litigation Settlement pay?
- The total settlement fund is $239M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the Celgene Corporation Securities Litigation Settlement?
- This settlement is closed to new claims — the deadline was April 13, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the Celgene Corporation Securities Litigation Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Celgene Corporation Securities Litigation Settlement notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at celgenesecuritieslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Celgene Corporation Securities Litigation Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for May 4, 2026; no payments can be issued before a settlement receives final approval.
Who's involved
Plaintiffs
- AMF Tjanstepension AB(Lead Plaintiff)
- AMF Tjnstepension AB(Lead Plaintiff)
- AMF PENSIONSFORSAKRING AB(Lead Plaintiff)
- MENORA MIVTACHIM PENSIONS AND GEMEL LTD.
- MENORA MIVTACHIM INSURANCE LTD.
- KRISTINE MATTHEWS
- CHARLES MATTHEWS
- KEVIN MATZKE
+ 3 more
Defendants
- PHILIPPE MARTIN
- Jonathan Q. Tran
- Peter Callegari
- ROBERT J. HUGIN(Consolidated Defendant)
- CHARLES H. WITCHCOFF(Consolidated Defendant)
- JACQUALYN A. FOUSE(Consolidated Defendant)
- TERRIE CURRAN
- NADIM AHMED
+ 4 more
Counsel for plaintiffs
- STEVEN J. DAROCISEEGER WEISS LLP
- AMF Tjnstepension ABPRO SE
- MENORA MIVTACHIM PENSIONS AND GEMEL LTD.PRO SE
- MENORA MIVTACHIM INSURANCE LTD.PRO SE
- KEVIN G. COOPERCARELLA BYRNE CECCHI BRODY & AGNELLO
- NATHAN HASIUKKESSLER TOPAZ MELTZER & CHECK, LLP
- MARGARET ELIN MAZZEOKESSLER TOPAZ MELTZER & CHECK LLP
- JOSHUA EDWARD D'ANCONAKESSLER TOPAZ MELTZER & CHECK LLP
- ANDREW ZIVITZKESSLER TOPAZ MELTZER & CHECK, LLP
- DAVID ANDREW BOCIANKESSLER TOPAZ MELTZER & CHECK LLP
- DARREN J. CHECKKESSLER TOPAZ MELTZER & CHECK, LLP
- PETER S. PEARLMANCOHN, LIFLAND, PEARLMAN, HERRMANN & KNOPF, LLP
- MARK A. FISHERTHE WOLF LAW FIRM, LLC
- ANDREW R. WOLFTHE DANN LAW FIRM PC
- JAMES E. CECCHICARELLA BYRNE CECCHI BRODY & AGNELLO, P.C.
Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
…moreHut 8 Corp. Securities Class Action Settlement
Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.
…more